A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT03818542 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Head and Neck Cancer

Interventions

DRUG: ABBV-181
DRUG: ABBV-368
DRUG: ABBV-927
DRUG: ABBV-927

Sponsor

AbbVie